ClinicalTrials.gg
RecruitingNCT06653543Updated Apr 27, 2025

Effect of Mulligan on Cervical Radiculopathy

An interventional study of Mulligan mobilization with arm movement and conventional therapy of cevical radiculopathy in Cairo University, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-04-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Radiculopathy by Cairo University — 22 open to participants now, 22 under way, none of them phase 3. Radiculopathy · Cairo University.

Planned enrollment
16th of 27
40 · median 45
Started
2025
with 4 others
No phase
26 of 36
15 open now
Primary completion
2025-03
later than 8 of 21 live
Registered
15th of 36
by date

Among the 36 studies in Radiculopathy by Cairo University, this one is the 16th largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2025, is one of 26 with no phase, reaches primary completion later than 8 of the 21 other live ones, and was the 15th registered.

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

Browse Radiculopathy studies →

Open to participants now

22 of the 36 studies in Radiculopathy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 22 open studies →

Where they have run

Who these studies take

Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.

This study: 20 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Radiculopathy by Cairo University, or all of them as a file.
02

Study summary

The goal of this clinical trial is to investigate the effect of Mulligan mobilization with arm movement on nerve conduction velocity in patients with unilateral cervical radiculopathy. The main questions it aims to answer are :

  1. Is there a statistical significant effect of mobilization with arm movement on NCV velocity in treatment of cervical radiculopathy ?
  2. Is there a statistical significant effect of mobilization with arm movement on pain level in treatment of cervical radiculopathy ?
  3. Is there a statistical significant effect of mobilization with arm movement on cervical ROM in treatment of cervical radiculopathy ?
  4. Is there a statistical significant effect of mobilization with arm movement on neck disability level in treatment of cervical radiculopathy ?

The course of treatment involves 6 sessions over the course of 3 weeks participants will be divided into 2 groups : Control group : recieves only Conventional treatment Experimental group : recieves Conventional treatment and Mulligan mobilization with arm movement .

Read the detailed description

the aim of our study is to examine the effect of Mulligan mobilization with arm movement on cervical radiculopathy using nerve conduction studies , in addition to the original measures of previous studies (pain level, cervical ROM and neck disability scale) .

Delimitations :

Inclusion Criteria

Individuals will be enrolled into the study if they are :

  • diagnosed with cervical radiculopathy .
  • Age group between 20-60 years
  • Unilateral radiating pain through the course of median nerve .
  • Subject having positive upper limb tension test (ULTT 1)
  • either gender male and female
  • Subjects who can understand the instructions and are willing to participate in the study.

Exclusion Criteria .

  • History of trauma, dislocation and subluxation of upper extremity
  • Rheumatoid Arthritis
  • Malignancy
  • Spinal canal stenosis .
  • Cervical instability/Spondylolisthesis
  • VBI (Vertebral-Basillar Insufficiency)
  • Referred pain in patients with cardiac ischemia
  • Cervical or thoracic spine surgeries
  • systemic causes like diabetic neuropathy.
  • recent fracture or surgery in and around the shoulder
  • carpal tunnel syndrome .
  • thoracic outlet syndrome .

Outcome measure would include:

A) The primary outcome measure will be NCV velocity, for the median nerve (latency, amplitude, Duration , F-wave and nerve conduction velocity of motor nerve action potentials and sensory nerve action potentials (SNAPs)) .

B) Secondary outcome measures will include:

  • Pain intensity, assessed using the Visual Analog Scale (VAS) .
  • Functional disability, evaluated using the Neck Disability Index (NDI) .
  • Cervical range of motion, measured using a CROM goniometer to assess flexion, extension, lateral flexion, and rotation.
  • The course of treatment involves 6 sessions over the course of 3 weeks .
  • pre-treatment for both groups :

    1. affected nerve conduction velocity will be measured using nerve conduction study .
    2. neck disability level will be measured using neck disability index .
    3. cervical ROM measurement will be taken in all directions using CROM goniometer .
    4. pain will be assessed using Visual analog scale .

participants will be divided into 2 groups :

Group A- Control group:

During each session : only Conventional treatment will be provided , includes : hot pack for 10 minutes, active ranges of motion (AROMs) with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition.

Group B- Experimental group- Mulligan mobilization group:

  • During each session :

    1. Conventional treatment will be provided .
    2. Mulligan mobilization will be applied in the form of : sustained passive accessory joint mobilization to a specific spinal vertebra level while simultaneously guiding the patient through an active, pain-free movement pattern involving the affected limb :
  • Patient position : Sitting upright on chair
  • Therapist position : Standing behind the patient .
  • Hand placement : Approach the desired level of spinous process from medial aspect of the thumb of one hand, which may be reinforced by the index finger of the other hand.
  • Mobilization Pure transverse glide is performed from affected to unaffected side. While the glide is sustained, patient performs the offending movements (flexion/abduction/horizontal adduction/horizontal abduction)
03

Conditions studied

  • Cairo University

Browse trials for

Keywords

  • mobilization
  • Mulligan
  • cervical
  • radiculopathy
04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • diagnosed with cervical radiculopathy .

      • Age group between 20-60 years
      • Unilateral radiating pain through the course of median nerve .
      • Subject having positive upper limb tension test (ULTT 1)
      • either gender male and female
      • Subjects who can understand the instructions and are willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

    • History of trauma, dislocation and subluxation of upper extremity

      • Rheumatoid Arthritis
      • Spinal canal stenosis .
      • Cervical instability/Spondylolisthesis
      • VBI (Vertebral-Basillar Insufficiency)
      • Referred pain in patients with cardiac ischemia
      • Cervical or thoracic spine surgeries .
      • systemic causes like diabetic neuropathy .
      • recent fracture or surgery in and around the shoulder .
      • carpal tunnel syndrome .
      • thoracic outlet syndrome .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    mulligan group

    20 participants recieving conventional therapy in addition to mulligan mobilization with arm movement

    Other: Mulligan mobilization with arm movement · Other: conventional therapy of cevical radiculopathy

  • Sham comparator
    control group

    control group that revieves only the conventional therapy

    Other: conventional therapy of cevical radiculopathy

Interventions

  • OtherMulligan mobilization with arm movement

    mulligan mobilization applied on cervical spine with arm movement

  • Otherconventional therapy of cevical radiculopathy

    hot pack for 10 minutes, active ranges of motion (AROMs) with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition

06

What researchers measure

Primary outcomes

  1. median nerve conduction study

    using nerve conduction studies to measure the median nerve (latency, amplitude, Duration , F-wave and nerve conduction velocity of motor nerve action potentials and sensory nerve action potentials ) .

    Time frame: 2 weeks

Secondary outcomes

  1. cervical range of motion

    using cervical CROM device to measure the cervical ROM in all 3 planes

    Time frame: 2 weeks

  2. pain

    using visual analogue scale for the pain intensity .. where no pain or discomfort(0) , while the severest pain (10) .. the more the pain , the more the points on the scale

    Time frame: 2 weeks

  3. neck disability level

    using neck disability index questionnaire consists of 10 items, where each item is scored on a scale of 0 to 5, with 0 indicating no disability and 5 indicating complete disability * The total score ranges from 0 to 50. * Higher scores indicate greater disability and impairment, while lower scores indicate less disability.

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
  • Kafr El-Sheikh university
    Kafr El-Sheikh Governorate, Kafr El-Sheikh 33516, Egypt
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Mar 2025, 2 months.

Of 205 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's 2 months is below that.

Counting every sponsor, half of 217 studies reached it within 12 months; a quarter within 5 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2024
First posted
Oct 22, 2024
StartActual
Jan 1, 2025
Primary completionActual
Mar 30, 2025
CompletionEst.
Aug 10, 2025
Last update
Apr 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06653543
Lead sponsor
Cairo University
Responsible party
Tawfik Mohamed Tawfik Elgazar (teaching assistant at the department of basic science, Cairo University) — Principal investigator
First posted
Oct 22, 2024
Start date
Jan 1, 2025
Primary completion
Mar 30, 2025
Completion
Aug 10, 2025 (estimated)
Last update
Apr 27, 2025

Study contacts

Elgazar
Contact
tawfiq.algazar_a010@pt.kfs.edu.eg
201013863820

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion